Interview With An AI Research Scientist Dr. Hector Palacios Joins Sal Peer of AI Exosphere & Founder of RISE Innovation

Rise Innovation Interview With Artificial Intelligence Research Scientist Dr. Hector Palacios.

Rise Innovation Interview With Artificial Intelligence Research Scientist Dr. Hector Palacios.

New RISE Innovation Episode featuring Dr. Hector Palacios who researches NeuroSymbolic methods, combining Machine Learning and Reasoning.

My mission is to continue bridging the gap and help bring in the new wave of innovative leaders.”

— Said Sal Peer, CEO of AI Exosphere

ORLANDO, FLORIDA, UNITED STATES, September 24, 2021 /EINPresswire.com/ — Interview with an AI Research Scientist Dr. Hector Palacios of Element AI, a ServiceNow company, joins Sal Peer, CEO of AI Exosphere and the Founder of the RISE Innovation Program.

Dr. Hector Palacios currently researches NeuroSymbolic methods, combining Machine Learning and Reasoning.

One is about using business context/knowledge to enhance the performance of pure machine learning methods.

The second is about incomplete but sound AI reasoning methods that deal with incomplete knowledge/models, including the output of pre-trained ML models.

For reasoning, Hector is interested in constraints, SAT, planning, and causal models. His industrial work has focused mainly on NLP, although he has worked with Vision, time-series, and operations research.

In academia, Hector produced award-winning work on AI reasoning, introduced new algorithms, and specialized in combining AI techniques.

So tune in to get informed, download some knowledge, and get inspired to innovate. The possibilities are endless.

"My mission is to continue bridging the gap and help bring in the new wave of innovative leaders," said Sal Peer CEO of AI Exosphere."— Sal Peer, CEO of AI Exosphere.

The episode airs on AI Exosphere's YouTube Channel on September 27th, 2021, at 9:00am EST. It is entertaining full of valuable insights, ethical questions, and creative inspiration from an artificial intelligence research scientist.

It would seem Sal has more episodes in mind which will be hosted on the AI Exosphere YouTube channel and become available to the RISE Innovation community.

About RISE Innovation Interview Series
RISE Innovation's creative team and our esteemed host Sal Peer, CEO of AI Exosphere, care about the integrity of each story and, most importantly, educate the audience. We believe the proper creative strategy must have clear and measurable objectives while simultaneously being rooted in education. Therefore, we strive to do meaningful interviews that inspire audiences to take action and join the innovation movement.

Sal Peer
AI Exosphere LLC
+1 888-578-2485
email us here
Visit us on social media:
Twitter
LinkedIn

Watch the RISE Innovation Interview Series on AI Exosphere’s new YouTube channel.


Source: EIN Presswire

Abbi Jones of Medpaper™ and Eco-pi™ to be Featured on Close Up Radio

NORTHPORT, ALABAMA, UNITED STATES, September 24, 2021 /EINPresswire.com/ — If you think about the qualities an entrepreneur needs, you will soon understand how Abbi Jones became one. They have to be curious and passionate. They have to have confidence in their ideas. Entrepreneurs also need the mindset to overcome challenges. When Abbi Jones launched her company Medpaper™ and its flagship product Eco-Pi™ she left a lucrative career in pharmaceutical sales to take a risk. She was also a single mother (with three young kids) and she started it just before the pandemic–a time when doctors were hesitant about office visitors. Abbi learned that nothing could scare her now, and that you just keep plugging. It all worked out, and the Medpaper™ team is now pursuing a patent on a second invention.

“My products make people say, geez, why didn’t I think of that?” Abbi says, “because the concept is so simple.” She realized what was needed in the medical space and created it: her first product, eco-pí, is a paper funnel that facilitates the collection of urine samples. The idea arose from a personal experience during Abbi’s pregnancy, as well as from interacting in doctor’s offices. The concept of controlling the urine stream while staying clean is something women can immediately associate with, and something that makes even more sense now that cleanliness precautions are a top priority.

Abbi’s flagship product was named eco-pi™ for several reasons, the foremost being a desire to lessen the amount of plastic used and discarded (just consider the magnitude of plastic samples at all the doctor’s offices and all the labs around the world that get tossed out on a daily basis!) Abbi had also travelled to Italy around that time (she has relatives there) and loved the way the Italians said “pe-pi.”

“I overheard things in doctor’s offices over the years. And I had personal struggles, especially while pregnant. I had this idea in my head that there should be some kind of device to funnel the urine into that little cup. I held onto that idea for a couple of years until some personal circumstances made me move on with it.”

Abbi cautions entrepreneurs to take their time developing, modifying and manufacturing a product. She notes that working with paper is not always easy, since it’s not a very malleable material, and that her current product went through several tweaks. Doing initial research, trials, and soliciting feedback were also important steps in product development. Abbi knows that having an idea, patenting it, and then manufacturing it are just the tip of the iceberg, and there is a long road of legal, financial and marketing work ahead; work that often requires the input of expert collaborators.

When Abbi talks about what she went through, how women felt, and how men took time to understand, you will be laughing as well as learning. Discover it all in this radio show.

Close Up Radio will feature entrepreneur Abbi Jones in an interview with Jim Masters on Thursday, Sept. 28th at 1:00pm EDT

Listen to the Show on BlogTalkRadio

If you have questions for our guest, please call 347-996-3369

For More information about the products, company and founder visit https://www.medpaper.us

Lou Ceparano
Close Up Television & Radio
+1 631-850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

New York Black College Expo™ Awarding Millions to Students

We are excited to host our 10th Annual New York Black College Expo™ this year. Although it will be virtual again this year, we look to award millions in scholarships through our college partners.”

— Dr. Theresa Price, Founder/CEO

DIAMOND BAR, CA, UNITED STATES, September 24, 2021 /EINPresswire.com/ — The virtual New York Black College Expo™ produced by National College Resources Foundation (NCRF) will be presented FREE on the Hopin platform, Friday, October 1, 2021, from 3:00 pm to 6:00 pm EDT. Due to COVID-19 safety precautions, we continue to provide access to colleges and universities through an online experience to the students of New York and the surrounding States.

At select institutions, students can get Accepted on the spot, get their college application Fees Waived, and receive Scholarships. This event will help high school seniors and college transfer students looking to transfer to a four-year college. Last year over 2 million dollars was awarded to students to attend college. In addition to getting connected to college recruiters, students have access to informative seminars and workshops.

New York State Senator Kevin S. Parker, District 21, will be partnering with NCRF to donate $2,000 in scholarships to deserving students.

“We are excited to host our 10th Annual New York Black College Expo™ this year. Although it will be virtual again this year, we look to award millions in scholarships through our college partners. We also are excited to have Dr. Guillermo Linares CEO of New York Higher Education Services Corp. join us to share the millions of dollars available to NY students”, says Dr. Theresa Price, Founder/CEO.

The expo is sponsored by Toyota, Nickelodeon, Honda, and powered by National College Resources Foundation and NCRF TV Network. This event will help students learn about various colleges, help high school seniors find a college home and also assist college transfer students looking to transfer to a four-year college. Educators, parents, guardians, and all ethnic backgrounds are welcomed to attend.

To register, please visit: www.ncrfoundation.org or call 877-427-4100.

About the Black College Expo™
Black College Expo™ (BCE) is a trademark program of National Colleges Resources Foundation (NCRF), a 501c3 non-profit organization that functions daily as a full-service students outreach program in various schools. BCE was founded in 1999 by Dr. Theresa Price as a vital link between minorities and college admissions. NCRF’s mission is to curtail high school dropout rate and increase degree and/or certificate enrollment among underserved, underrepresented, at-risk, low resource, and homeless and foster students. NCRF’s vision is to close the gap in educational achievement, workforce, and economic disparities with the goal to end racism and racial inequalities.

Joan Scott
National College Resources Foundation
+1 210-834-9964
joan@ncrfoundation.org
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Covid-19, Viral Vector & DNA and mRNA Based Vaccines Catapults the Billion Dollar Vaccine Market

Clairvoyance Research

Vaccines Market

Vaccine – Savior of Mankind

Viral vector, nucleic acid-based vaccines, fast-growing Shingles, Varicella & IPV vaccines and combination vaccines key drivers of global vaccines market

PORTLAND, OREGON, UNITED STATES, September 24, 2021 /EINPresswire.com/ — The Global Vaccines Market is expected to clock US$ ~93.17 billion by 2031 owing to technological advancements such as viral vector and nucleic acid-based vaccines (DNA and mRNA vaccines), fast-growing Shingles, Varicella & IPV vaccines, rising birth rate, outbreak of several vaccine preventable diseases, rising adoption of combination vaccines, robust product pipeline of key players and growing government initiatives for immunization programmes.

Clairvoyance Research conducted an in-depth market analysis study of the global vaccines market. The study comprehensively analyzes the market from different perspectives and provides granular insights on hot revenue pockets, headwinds & tailwinds impacting the market, quantitative (market size & forecasts) and qualitative analysis from ‘Patient Type, Strain Type, Technology, Vaccine Type, Route of Administration and Region’ perspective, product pipeline, and competitive landscape.

Access ‘Sample Pages’ of the Report

Key Market Trends

The ongoing pandemic of COVID-19 has affected almost every country worldwide, and resulted in severe outcomes, across all these regions. Several organizations and prominent players are making collaborative efforts to provide vaccines to different countries and to help them address new challenges by guaranteeing the continuous & efficient supply of COVID-19 vaccines in priority areas. Incessantly rising number of people infected with COVID-19, favorable funding's & incentives from global governments and foundations for vaccine development and promising R&D landscape for COVID-19 vaccines are some of the pivotal factors which are expected to bolster its demand in the coming months/years. Currently, R&D landscape for COVID-19 vaccines includes 115 vaccine candidates. Global organizations/foundations such as WHO, CEPI, WHO, Bill and Melinda Gates Foundation are also increasingly providing incentives to vaccine manufacturers for large-scale production of SARS-CoV-2 vaccines. COVID-19 Vaccines Global Access (COVAX), a worldwide initiative aimed at equitable access to COVID-19 vaccines, co-led by CEPI, Gavi and WHO, alongside key delivery partner UNICEF has also played an instrumental role in driving the global COVID-19 vaccines market.

The global vaccines market has been analyzed from six different perspectives – Patient Type, Strain Type, Technology, Vaccine Type, Route of Administration and Region.

Key Takeaways – Vaccine Type Perspective

PCV, D&T-containing, HPV and influenza vaccines generate the highest market value while new vaccines such as Shingles, Varicella, IPV are expected to propel the market growth in the coming years. Technological advancements such as mRNA and vector vaccines, continously rising prevalence of infectious diseases, rising government focus on immunization programs and robust product pipeline are some of the key factors that are expected to drive the demand of vaccines globally.

Key Takeaways – Technology Perspective

Recombinant vaccines segment is expected to be the fastest growing segment in the market during the forecast period. The growth of the segment can be mainly attributed to development and launch of several recombinant vaccines.

Snapshot – Competitive Landscape

The vaccines market is marked by presence of prominent players such as Merck & Co., Sanofi, GlaxoSmithKline plc., Pfizer Inc., AstraZeneca, CSL Limited, Panacea Biotec Ltd., Serum Institute of India Pvt. Ltd., PT Bio Farma (Persero), Bavarian Nordic, among others. Other players operating in the market are Bharat Biotech, Emergent BioSolutions Inc., Johnson & Johnson Private Limited, Mitsubishi Tanabe Pharma Corporation, among others.

For deep-rooted insights, please explore the Report

NEED MORE?

Talk to us about your requirements and get a customized report
Get more details about the content of report
Request ‘Sample Pages’ of the report

Vinit Singh
Clairvoyance Research
+91 8761988338
email us here


Source: EIN Presswire

AAEON Systems Leverage Greater Security Benefits from Partnership with Allxon

BOXER-8230AI, Preliminary Image, final product may differ.

AAEON An Asus Company

AAEON An Asus Company

New partnership allows users to leverage benefits of remote device management with robust IoT security software to keep their data and edge applications safe.

Our partnership with Allxon enables our clients to leverage TMIS to protect their AI Edge applications and provide vital data security.”

— Alex Hseuh

TAIPEI CITY, TAWIAN, September 24, 2021 /EINPresswire.com/ — AAEON, a leader in Edge Computing hardware solutions, continues to grow their partnership with Allxon. Allxon recently announced their partnership with Trend Micro to deliver industry-leading cybersecurity software for systems running NVIDIA® Jetson™ JetPack 4.6 and onward. Through its cooperation with Allxon, AAEON has become the first Edge IoT hardware manufacturer to support Allxon remote device management with Trend Micro security on box PCs powered by NVIDIA Jetson SOMs.

The quickly growing popularity of Edge AI devices has attracted the rapid emergence of AI and IoT threats. In light of recent high-profile attacks, it is becoming more apparent that a multi-layered approach to data security at both the cloud and the edge is needed. For this reason, Allxon has partnered with Trend Micro, integrating the Trend Micro IoT Security (TMIS) into Allxon’s suite of remote device management tools.

Allxon remote device management enables the prevention of cyberattacks on every AAEON platform and provides developers and customers with an important solution to deploy Edge AI applications based on the Jetson platform securely in the field.

Through AAEON’s partnership with Allxon, clients who purchase AAEON BOXER-8200AI series systems powered by NVIDIA JetPack 4.6 will have access to this combination of remote monitoring with cybersecurity. The BOXER-8200AI systems each come with a link allowing users to download the Allxon trial suite. Users who wish to purchase the full version of the Allxon software can do so via Allxon. The NVIDIA JetPack 4.6 production release supports the full Jetson edge AI platform lineup, including the new Jetson AGX Xavier™ industrial module. It also includes support for NVIDIA Triton™ Inference Server, updated versions of CUDA®, cuDNN and TensorRT™, new over-the-air (OTA) updates and security features, and more.

“Our partnership with Allxon enables our clients to leverage TMIS to protect their AI Edge applications and provide vital data security,” said Alex Hsueh, Associate Vice President of AAEON’s System Platform Division. “AAEON is committed to providing customers with the tools they need to accelerate deployment, and by providing a direct connection between them and our partner Allxon, users don’t have to waste time looking for the right software solution for their application.”

AAEON and Allxon are both Preferred Partners in the NVIDIA Partner Network, working closely with NVIDIA to build and develop industry-leading solutions for the Jetson ecosystem. For more information, read Allxon’s press release at: https://www.allxon.com/news/allxon-delivers-even-stronger-and-safer-remote-ai/iot-solutions-in-partnership-with-trend-micro-for-nvidia-jetson-edge-ai-platform

________________________________________________________________________________________
About Allxon
Allxon envisions a world of open and optimized business operations. Allxon partners with key IHV and ISV players by rolling out efficient open- edge device management solutions for powerful SI and MSP business enterprises. With team members rallying deep industry experience starting in 2001 in IaaS, 2011 in PaaS, and 2017 in SaaS, in 2019 established Allxon now stands firmly as a purely SaaS service provider. At each stage, Allxon seeks to leverage expertise in cloud service to provide businesses with the best of software and hardware integration and service. Learn more about Allxon at www.allxon.com.

About AAEON
Established in 1992, AAEON is one of the leading designers and manufacturers of industrial IoT and AI Edge solutions. With continual innovation as a core value, AAEON provides reliable, high-quality computing platforms including industrial motherboards and systems, rugged tablets, embedded AI Edge systems, uCPE network appliances, and LoRaWAN/WWAN solutions. AAEON also provides industry-leading experience and knowledge to provide OEM/ODM services worldwide. AAEON also works closely with cities and governments to develop and deploy Smart City ecosystems, offering individual platforms and end-to-end solutions. AAEON works closely with premier chip designers to deliver stable, reliable platforms, and is recognized as an NVIDIA® Preferred Partner. For an introduction to AAEON’s expansive line of products and services, visit www.aaeon.com.

AAEON Sales
AAEON Technology Inc.
+886 289191234
email us here


Source: EIN Presswire

COUNTDOWN COP 26: Meta-Narrative to embed Indigenous Climate perspectives in San Francisco Bay Ecotarium

A waterfall projection exhibit in the future Bay Ecotarium will immerse visitors into the practices and lifestyles of native American stewardship

The 2nd pod of the future Bay Ecotarium will contain an immersive theater, “Blue” restaurant and bar and deep ocean submersibles

World’s first Climate and Ocean Conservation Living Museum being designed in San Francisco to leverage native American voices, immersive tech & LEED Gold rating

SAN FRANCISCO, CA, UNITED STATES, September 23, 2021 /EINPresswire.com/ — World’s first Climate and Ocean Conservation Living Museum being designed in San Francisco, to leverage Native American environmental stewardship, Silicon Valley technologies including Ai, EAi, Cloud networking, Mobile AR/ VR overlays, immersive experiences, projected holograms, and Deep Learning in its bio-mimetic LEED Gold building Design.

For Immediate Release

San Francisco, CA- When George Jacob arrived to lead the now Smithsonian Affiliated Aquarium of the Bay on PIER 39 in San Francisco 5 years ago as its first President & CEO, his assessment of the ageing facility, prompted the genesis of a vision to transform it into a $260 million environmental edifice unlike any other, dedicated to Climate Change and Ocean Conservation- the Bay Ecotarium.

Jacob led an international team of experts drawn from France, Canada, Germany and Japan to unveil an iridescent, organic, bio-mimetic design inspired by ocean geometry, fish-scales, rippling waves and Ohlone shell-mounds.

Unlike conventional science museum exhibits that often tend to deliver an overdose of data, graphs and technical analysis, the Ecotarium is an evocative platform that is programmed for a three-part trigger. First, to appreciate the wondrous beauty of our Blue Marble we call home in all its magical biodiversity and delicate and complex balance of the web of life. Second, to feel the anguish of a planet in pain that remained silent to the Anthropocene and then began exploding with ominous fury that is existential for human-kind. Third, to remember that our collective future relies on us taking decisive action- be it with programs, policy or personal lifestyle choices driven by sustainability and 360 circular economies. The soul of the Ecotarium is a 2 million gallon saltwater aquarium with 300 species and 30,000 animals that offers a lens to life – silent and unseen – below the depths of the ocean.
Indigenous environmental stewardship in mitigating Climate Change is integral to conservation efforts-locally and globally. With the office of the President Joe Biden naming representative Deb Haaland of New Mexico as the Interior Secretary, creating history while honoring heritage, a new era for the environment awaits in the United States. Native American Laguna Pueblo lineage makes her the first Native American to ever hold a Cabinet Secretary level position.

A co-sponsor of the Green New Deal, Deb Haaland brings a unique indigenous perspective to environmental leadership as she prepares to be at the helm of natural resources and land. With 574 federally recognized tribes holding sovereign treaties with the United States, their numbers are upwards of 5 million with about 78 percent living outside reservations.

Indigenous Peoples of the world comprise 5 percent of the world’s population and live on 22 percent of the land that is home to over 75 percent of the global biodiversity. According to the 2018 IPCC Report (Inter-government Panel on Climate Change), the native symbiosis with environment is synonymous with climate solutions. The Special UN IPCC Report on climate change, desertification, land degradation, sustainable land management, food security, and greenhouse gas fluxes in terrestrial ecosystems, draws on indigenous perspectives and practices. Everything from the rotation of crops, plant palette of native species, conservation and forest management practices, water distribution, hunting and fishing levels of consumption, recycling, burning cycles, terrain and geographical nuances, seasonal adaptations, curation of flora and fauna, recognizing vectors of pollination and cross-pollination, movement of livestock, will be at play in regulated measures seeking 360-degree circular economies both at the micro and macro levels. From Treaty obligations to Earth Justice, the list of complex issues is long and multi-generational, braided with emotional and trust issues of marginalization, racism, and the specter of ‘climate refugees’ from the tiny pacific island of Kiribati to the mighty burning greens of the Amazon. With over 18,500 indigenous peoples, tribal traditions in the San Francisco Bay Area and languages have survived through sheer tenacity of elders and youth.

Being in the mecca of Tech, IT will play a major role in the guest experiences of the Bay Ecotarium. Augmented and Virtual reality will immerse visitors into scenarios of real climate change crisis examples and provide an elevated sense of urgency for immediate action. Machine learning, emotional intelligence, google driven visual mapping and real-time user engagement will be utilized to further these experiences and create inspiring messaging that translates into real action. The VR platform component of the building can transcend geo-political boundaries and engage upwards of 2 billion people, despite the physical footprint projections of 2 million visitors per year.

The Bay Ecotarium is a movement- BE the movement!

Hunter Coughlin
Bay Ecotarium
+1 203-974-3463
hunter@bayecotarium.org
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Image Retrieval Announces Partnership with German Company CRUSE to Distribute & Support CRUSE Products in US & Canada

Image Retrieval partners with CRUSE as the company expands its offerings into new industries.

CARROLLTON, TEXAS, UNITED STATES, September 23, 2021 /EINPresswire.com/ — Image Retrieval Inc., a reseller of high-resolution scanning equipment for cultural heritage materials, is pleased to announce its new partnership with CRUSE, a German company that creates scanners specifically for the art, museum and décor industry. According to Image Retrieval President Derek Jenkins, the company is excited to provide distribution and support for CRUSE products in the U.S.A. and Canada.

“We are delighted to make the announcement about our new partnership,” says Jenkins. “CRUSE is renowned the world over for its top-quality high-end scanners, which are manufactured using the latest scanning technology. It’s an honor for us to work with such an enterprising company, and we look forward to further increasing the distribution of these remarkable products within North America.”

The CEO of CRUSE, Heinrich Kannen, says the partnership will be beneficial to both companies for a number of reasons:

“Our partnership with Image Retrieval creates tremendous new opportunities for us within the U.S. and Canadian markets. Our scanners are designed especially for our customers in the art, museum and décor industries, and are particularly helpful for use with sensitive documents and originals. With the assistance of Image Retrieval, we will be able to provide solutions and services for more people in those industries in North America.”

For more information about Image Retrieval’s products and the scanning services it offers, visit the website at www.iiri.com.

About Image Retrieval Inc.

Established in 1990, Image Retrieval is a reseller of high-resolution scanning equipment for cultural heritage materials, including books, maps, microfilm, documents, and newspapers. The company offers a wide range of planetary, microfilm, and document scanners for libraries, archives, and government agencies. It also offers fast and professional scanning services out of their offices in Carrollton, TX, specializing in scanning books, microfilm, and microfiche.

About CRUSE

A German specialist leading the world in high-end scanners, CRUSE has been a reliable partner for the design and printing industry, art reproduction, museums, archives and libraries since 1979. The company currently operates in over 30 countries across the world, with over 1000 scanners in operation. With 95% of their manufacturing completed in-house, CRUSE prides itself on its innovative use of the latest in scanning technology and its ability to provide customers with high-quality custom-made products.

Sam Khalil
Image Retrieval, Inc.
+1 972-492-0930 ext. 64
sales@iiri.com


Source: EIN Presswire

Smart Glasses with a Purpose: Tokyo Company Launches AI Technology to Protect Users’ Eyes

Smart glasses Ai glasses logo

Ai Glasses smart glasses logo

Smart glasses for adults

Ai Glasses smart glasses for adults

Smart glasses for children

Ai Glasses smart glasses for children

HoldOn Ai/ Glasses Designed to Prevent Bad Habits like Eye Strain and Bad Posture

NISHISHINJUKU, SHINJUKU-KU, TOKYO, JAPAN, September 23, 2021 /EINPresswire.com/ — As smart glasses continue their rise in popularity, one company in Tokyo is taking the trend a step further by using artificial intelligence to help protect the person wearing them. Unlike traditional smart glasses that are primarily used for hands-free demands, HoldOn Ai/Glasses come equipped with alerts that analyze if a person is sitting too close to a device, if the lighting is too dark for reading, and even if they’re slouching or exhibiting bad posture.

Developed by leading Japanese lifestyle product manufacturer, ClearElectron, HoldOn Ai/Glasses will be introduced to the United States market for the very first time this month at the Vision Expo West 2021 in Las Vegas. Attendees are invited to sample the glasses which also boast a corresponding app that delivers customized reports on the wearer’s screen time on devices like smartphones, laptops and TVs to help them develop good habits. Likewise, the glasses are blue light blocking, providing excess protection against the harmful eye-damaging ray, which may impact retinal cells.

The launch comes on the recent reveal that screen time is at an all-time high, resulting from the COVID-19 pandemic. Research found that adults over the age of 18 experienced an increase in overall screen usage during by as much as 40 percent during that period. And with more people working from home, HoldOn Ai/Glasses can provide a benefit to employees, prompting them to take more frequent breaks and ensure their remote workstation is providing them with maximum comfort.

“Knowing how many more people are spending time on their phones and computers these days, we wanted to reinvent the notion of smart glasses to provide a benefit for users and help them lock in these good habits now,” said Shiken Ono, CEO of ClearElectron. “The HoldOn Ai/Glasses provide real-time data to help them make those lifestyle changes.”

In addition to screen reading, the HoldOn Ai/Glasses can also be worn while driving. Special sensors alert drivers if they start to doze off by identifying the shifting position of their neck and ultimately making the road a safer place. HoldOn Ai/Glasses also provide benefits to children including notifying parents of the time a child spends on their digital devices.

Those interested in being one of the first to experience HoldOn Ai/Glasses can stop by the product’s booth #P21075 at Vision Expo West, held Thursday, September 23 – Saturday, September 25 at the Sands Expo & Convention Center inside the Venetian. For more information, visit www.HoldOnAiGlasses.com.

About HoldOn Ai/ Glasses

HoldOn Ai/Glasses are a revolutionary line of smart glasses designed to protect users’ eyes and help them develop healthy neck and back habits. Developed by leading Japanese lifestyle manufacturer ClearElectron, the first-of-its-kind glasses are equipped with benefits including alerts for when someone is sitting too close to a device or exhibiting bad posture. For more information on HoldOn Ai/ Glasses, visit their official website at www.HoldOnAiGlasses.com or the ClearElectron company website at www.ClearElectron.com.

Thomas Tanoue
ClearElectron Co., Ltd.
+13108179450 ext.
email us here
Visit us on social media:
LinkedIn

Ai/Glasses are smart glasses from Tokyo that uses AI to correct bad posture and protect your eyes.


Source: EIN Presswire

Environmental Groups Urge Governor Inslee to Appoint New Fish & Wildlife Commissioners

Request Points to Need for Reform After Auditor’s Report Reveals Problems in Agency Culture

We are at a turning point for the direction of the state Department of Fish and Wildlife, and for the survival of many fish and wildlife species within the state.”

— Washington Wildlife First Interim Executive Director David P. Linn

SEATTLE, WASHINGTON, UNITED STATES, September 23, 2021 /EINPresswire.com/ — Representatives from twelve environmental and wildlife protection organizations sent a letter to Washington Governor Jay Inslee this week, urging him to immediately appoint two new members to the Washington Fish and Wildlife Commission.

One seat on the nine-member Commission is currently vacant, while Chairman Larry Carpenter has continued to serve on the Commission even though his term ended nearly a year ago. The Commission sets fish and wildlife policy and has supervisory authority over the Department of Fish and Wildlife.

“We are at a turning point for the direction of the Fish and Wildlife Commission, and for the survival of many fish and wildlife species within the state,” said David P. Linn, interim executive director for Washington Wildlife First, a new state nonprofit dedicated to reforming the state’s wildlife management.

“In order to effectively cope with the dual threats of climate change and the accelerating loss of biodiversity, we need to have a full Commission in place that values and understands science, has a commitment to ethical wildlife management, and is dedicated to conserving our fish and wildlife species,” Linn said.

This request to the Governor comes a week after the Washington State Auditor’s Office released a performance audit on the workplace culture at the Department of Fish and Wildlife.

“The auditor’s report confirmed what people within the Department have long been telling us,” said Claire Loebs Davis, president of Washington Wildlife First.

“There are many excellent scientists, enforcement officers, conflict specialists and other employees within the Department, who have dedicated their careers to protecting and conserving Washington’s fish and wildlife.” Davis said. “But they cannot do their jobs when they are working in a hostile environment, where unprofessional, unethical, and illegal behavior is rampant, supervisors are not held accountable, employees are bullied, and people fear retaliation for speaking out.”

The auditor found that one in ten WDFW employees has directly witnessed someone within the Department committing a legal or ethical violation in the past year, while a slightly larger number have directly suffered from retaliation after reporting illegal and unethical behavior, disagreeing with a supervisor—and even, in some cases, for talking to the auditors.

More than 25% of employees interviewed reported incidents of sexual discrimination, while more than 20% of those surveyed had been bullied at work, often due to gender. Although women comprise more than half the workforce in other state agencies, less than one-third of WDFW employees are women.

“The good ole’ boys club is alive and well at WDFW,” Davis said. “Employees have been asking Department managers and Fish and Wildlife Commissioners for help for a long time, but nobody has been listening. We are hoping Governor Inslee will show he is listening now.”

Linn said many employees within the Department are desperate for new leadership at the Commission.

“We need Fish and Wildlife commissioners who will not only follow science, but who will have the dedication and moral compass to guide the agency in a new direction,” Linn said. “We are calling on Governor Inslee to take a stand, not only for the state’s fish and wildlife, but for the brave employees who risked their jobs by speaking to the state auditor. They need to know that their voices have been heard.”

Joining Washington Wildlife First in the letter to Governor Inslee are Cascadia Wildlands, Center for Biological Diversity, Defenders of Wildlife, Humane Society of the United States, Kettle Range Conservation Group, Mountain Lion Foundation, Northwest Animal Rights Network, Predator Defense, Western Watersheds Project, Western Wildlife Outreach, and WildEarth Guardians.

Claire Loebs Davis
Washington Wildlife First
+1 206-601-8476
email us here


Source: EIN Presswire

Xuanzhu and SignalChem Lifesciences Announce Collaboration and Licensing Agreement for SLC-391 in Greater China

An innovative clinical stage biotech company in China

Headquartered in Richmond, British Columbia, Canada, a clinical-stage company developing novel targeted therapies for oncology

BEIJING, BEIJING, CHINA, September 23, 2021 /EINPresswire.com/ — Beijing, China and Richmond, British Columbia, Canada — Sihuan Pharmaceutical Holdings Group Ltd., together with its subsidiaries and SignalChem Lifesciences Corporation today announced that Sihuan Pharmaceutical Holdings Group Ltd subsidiary company Xuanzhu Biopharmaceutical Co., Ltd. ("Xuanzhu") and SignalChem Lifesciences Corporation ("SignalChem") have entered into an exclusive collaboration and licensing agreement for the clinical development and commercialization of SLC-391, a potent and selective AXL targeting inhibitor, in the Greater China region.

Under the terms of the agreement, Xuanzhu will pay to SignalChem an upfront fee of thirteen million US dollars (US$13,000,000). Additional development milestones and royalties have also been committed. The exclusive rights for SLC-391 for the field of oncology is for the Greater China region (Mainland China, Hong Kong, Macau and Taiwan).

AXL is a member of TAM (Tyro3, AXL, Mer) family of receptor tyrosine kinases. AXL along with its ligand GAS6 (growth arrest-specific gene 6) is highly expressed and activated in many malignant tumors, such as acute myeloid leukemia, kidney, pancreatic, breast, lung and ovarian cancer, etc. As one of the crucial signaling pathways promoting tumor growth and metastasis, immune escape and drug resistance, GAS6-AXL pathway is considered to be an attractive target for cancer treatment and has attracted widespread attention.

"The agreement with SignalChem will further advance Xuanzhu's pipeline in the solid tumor and hematoma space. The results from preclinical and phase 1 clinical development demonstrated SLC-391 superiority not only as SLC-391 has prominent single-agent activities in multiple solid and hematological tumors but also can potentially be administered with a variety of drugs under development at Xuanzhu. Both parties will use their respective resources to accelerate the clinical approval of SLC-391 in China,” said Ms. Xu Yanjun, Chairman of Xuanzhu. “Xuanzhu will continue to expand its efforts to develop and commercialize innovative drugs in the oncology field."

“Xuanzhu Biopharmaceutical, a subsidiary of Sihuan Pharmaceutical, is a highly innovative and progressive company,” commented by Mr. Jun Yan, the Chairman and President of SignalChem, “We are very pleased to establish a partnership with Xuanzhu. This licensing agreement is of great significance for SignalChem to further validate and expand SLC-391’s clinical superiority. This agreement will accelerate SLC-391’s development timeline to reach the market and provide more effective treatment alternatives for patients with cancer.” Mr. Jun Yan added, “the size of the agreement, including upfront, milestone and royalties, with Xuanzhu may be one of the largest agreements signed in Canada with a Chinese bio-pharma company for the Chinese territory rights, and we are looking forward to reaching all anticipated objectives. Furthermore, SignalChem will continue its efforts to expand and accelerate clinical development with SLC-391 for wider indications in even more geographic territories.”

About SLC-391
SLC-391 is a potent, highly selective and orally bioavailable small molecule AXL inhibitor. Preclinical investigational data shows SLC-391 is a superior AXL inhibitor and has the potential to become a first-in-class inhibitor. Phase I clinical study is currently underway in Canada. SignalChem has established a collaboration with Merck (MSD) to evaluate the efficacy of SLC-391 in combination with Keytruda® (pembrolizumab) for the treatment of advanced non-small cell lung cancer (NSCLC). In pre-clinical studies, SLC-391 demonstrated strong efficacy as a single agent or in combination with other approved drugs in multiple animal models for cancer. SLC-391 will be developed to undisclosed cancer indications as a single agent or in combination with other therapies.

About Xuanzhu
Xuanzhu Biopharmaceutical Co., Ltd., a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd., is an innovative biopharmaceutical company rooted in China with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production commercialization. Xuanzhu's strengths reside in its detailed knowledge and expertise in the clinical development and regulatory approval processes in China. Xuanzhu has a clinical and regulatory team of over 300 people bringing expertise from numerous multinational pharmaceutical companies including J&J, Lilly, Merck, Novartis, Pfizer, and Roche. This combined with the most extensive sales and marketing capability in China, places Xuanzhu as the premier partner for those companies with innovative assets desiring to enter the China domestic market.

About SignalChem Lifesciences Corporation
SignalChem Lifesciences Corporation, headquartered in Richmond, British Columbia, Canada, is a clinical-stage company developing novel targeted therapies for oncology. Its unique business model has been built upon four important pillars: Drug Discovery and Development, the Bioreagents and Research Services business, In-Vitro Diagnostic Reagent Development and Plant Biosynthesis Systems. We at SignalChem are a group of scientists with extraordinary expertise and experience in protein engineering and drug discovery who are working together cohesively to provide the best products and services to our customers around the world and to maximize the efficiency of our own drug discovery efforts.

Deyan Hou
XUANZHU Biopharmaceutical Co. Ltd
+86 186 1269 2542
houdeyan@xuanzhubio.com


Source: EIN Presswire